drugset / Trial / NCT05227742
Exploratory Study of Low Dose Psilocybin
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the present study is to evaluate the feasibility, initial signals of efficacy, and potential mechanisms of action of "microdoses" of psilocybin (i.e., low doses of psilocybin that are not believed to produce mystical-type, transcendent, hallucinogenic, or other overtly salient subjective effects that limit functionality) in the treatment of moderate to severe demoralization (feelings of hopelessness and meaningless that frequently accompany medical illness and other life hardship).
Timeline
- Start
- 2023-08-15
- Primary completion
- 2026-03
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 1 mg | Oral |
| Subject | Psilocybin | Other / unclassified | 2.5 mg | Oral |
| Subject | Psilocybin | Other / unclassified | 5 mg | Oral |
Indications
No indication recorded.